Thank you, Mr. Chair.
Thank you, everyone, for your presentations.
I want to start off with the Canadian Stem Cell Foundation with a quick question, if you can provide some colour concerning your comment about our research prowess and—I don't want to say the word failure—the inability to have that research prowess translated into the commercialization of those activities.
I know the ask; my understanding is it's $50 million, for a total of $500 million in federal funds over 10 years. Stepping back from the ask, what's the greatest barrier preventing this research prowess from being turned into commercialization of products and services?